Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy. Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, et al. N Engl J Med 2025;393:823-825.

Read + Share

Amedeo Smart

Independent Medical Education

Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, et al. Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy. N Engl J Med 2025;393:823-825.
PMID: 40834307